Clinical Trial: A Study of IMM0306 in IgG4-Related Disease

U.S., June 3 -- ClinicalTrials.gov registry received information related to the study (NCT07621939) titled 'A Study of IMM0306 in IgG4-Related Disease' on May 17.

Brief Summary: The goal of this clinical trial is to learn if IMM0306 works to reduce the risk of disease relapse in participants with IgG4-related disease (IgG4-RD). It will also learn about the safety and tolerability of IMM0306. The main questions it aims to answer are:

* Does IMM0306 reduce the risk of disease relapse in participants with IgG4-RD?

* What medical problems do participants have when receiving IMM0306?

* How does IMM0306 behave in the body, and does the body develop anti-drug antibodies against IMM0306? In the Phase II part, all participants will receive IMM03...